FDA.reportPublic FDA data

METACRESOL

Substance profile for UNII GGO4Y809LO, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for METACRESOL
Structure render from PubChem CID 342

Substance Identity#

UNII
GGO4Y809LO
Preferred term
METACRESOL
Registry number
108-39-4
EC number
203-577-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C7H8O
Chemical structure for METACRESOL
Structure render from PubChem CID 342

Chemical And Database Identifiers#

InChIKey
RLSSMJSEOOYNOY-UHFFFAOYSA-N
SMILES
CC1=CC(O)=CC=C1
RxCUI
1367170
PubChem
342
NCIt
C80603
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound342https://pubchem.ncbi.nlm.nih.gov/compound/342
PubChem InChIKey SearchRLSSMJSEOOYNOY-UHFFFAOYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=RLSSMJSEOOYNOY-UHFFFAOYSA-N
RxNorm1367170https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1367170
NCI ThesaurusC80603https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80603
FDA Substance Registration SystemGGO4Y809LOhttps://precision.fda.gov/uniisearch/srs/unii/GGO4Y809LO
European Community number203-577-9https://commonchemistry.cas.org/results?q=203-577-9

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
METACRESOLINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog. NovoLog (insulin aspart [rDNA origin] injection) solution for subcutaneous use Initial U.S. Approval: 2000 ®2
METACRESOLINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
METACRESOLINACTIVE INGREDIENTGGO4Y809LONovolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) ®2
METACRESOLINACTIVE INGREDIENTGGO4Y809LONovolin N NPH, Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL2
METACRESOLINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog. NovoLog ® (insulin aspart [rDNA origin] injection) solution for subcutaneous use Initial U.S. Approval: 20001
METACRESOLINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use Novolin R safely and effectively. See full prescribing information for Novolin R. Initial U.S. Approval: 1991 Novolin R (Regular, Human Insulin [rDNA origin] USP) solution for subcutaneous or intravenous use ®2
MetacresolINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 19962
MetacresolINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 19963
metacresolINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA ® (exenatide) Injection Initial U.S. Approval: 20053
METACRESOLINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use LEVEMIR ® safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR ® (insulin detemir [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20052
METACRESOLINACTIVE INGREDIENTGGO4Y809LONovolin ® 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)2
METACRESOLINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20001
METACRESOLINACTIVE INGREDIENTGGO4Y809LOLevemir ® (insulin detemir [rDNA origin] injection)1
MetacresolINACTIVE INGREDIENTGGO4Y809LOHUMULIN ® R REGULAR INSULIN HUMAN INJECTION, USP (rDNA ORIGIN)100 UNITS PER ML (U-100)2
METACRESOLINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use NovoLog Mix 70/30 safely and effectively. See full prescribing information for NovoLog Mix 70/30. NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) Suspension for subcutaneous injection Initial U.S. Approval: 20012
METACRESOLINACTIVE INGREDIENTGGO4Y809LO81f28314-31c8-4114-a4b3-336eb20945581
METACRESOLINACTIVE INGREDIENTGGO4Y809LO44863566-b55c-422d-adbd-5454a70b68a91
METACRESOLINACTIVE INGREDIENTGGO4Y809LOThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
MetacresolINACTIVE INGREDIENTGGO4Y809LOHUMALOG (INSULIN LISPRO) INJECTION, SOLUTION HUMALOG KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION [ELI LILLY AND COMPANY]49
MetacresolINACTIVE INGREDIENTGGO4Y809LOHUMALOG MIX50/50 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY]32
MetacresolINACTIVE INGREDIENTGGO4Y809LOHUMALOG MIX75/25 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX75/25 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY ]31
MetacresolINACTIVE INGREDIENTGGO4Y809LOFORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY]23
MetacresolINACTIVE INGREDIENTGGO4Y809LOHUMULIN R (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY ]22
METACRESOLINACTIVE INGREDIENTGGO4Y809LOLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION LANTUS SOLOSTAR (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]22
metacresolINACTIVE INGREDIENTGGO4Y809LOBYETTA (EXENATIDE) INJECTION [AMYLIN PHARMACEUTICALS, LLC]20
METACRESOLINACTIVE INGREDIENTGGO4Y809LONOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK]19
METACRESOLINACTIVE INGREDIENTGGO4Y809LONOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK]16
metacresolINACTIVE INGREDIENTGGO4Y809LOAPIDRA (INSULIN GLULISINE) INJECTION, SOLUTION APIDRA SOLOSTAR (INSULIN GLULISINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]15
MetacresolINACTIVE INGREDIENTGGO4Y809LOHUMULIN R U-500 (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY ]15
METACRESOLINACTIVE INGREDIENTGGO4Y809LOLEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK]15
metacresolINACTIVE INGREDIENTGGO4Y809LOREMODULIN (TREPROSTINIL) INJECTION, SOLUTION [UNITED THERAPEUTICS CORPORATION]14
METACRESOLINACTIVE INGREDIENTGGO4Y809LODEMEROL (MEPERIDINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]12
METACRESOLINACTIVE INGREDIENTGGO4Y809LONOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK]12
metacresolINACTIVE INGREDIENTGGO4Y809LOSYMLINPEN (PRAMLINTIDE ACETATE) INJECTION [AMYLIN PHARMACEUTICALS, LLC]11
METACRESOLINACTIVE INGREDIENTGGO4Y809LONOVOLIN N (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK]10
METACRESOLINACTIVE INGREDIENTGGO4Y809LONOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK]9
METACRESOLINACTIVE INGREDIENTGGO4Y809LOSAIZEN (SOMATROPIN) KIT SAIZEN CLICKEASY (SOMATROPIN) KIT [EMD SERONO, INC.]7
metacresolINACTIVE INGREDIENTGGO4Y809LOTOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]7
METACRESOLINACTIVE INGREDIENTGGO4Y809LOGONAL-F RFF PEN (FOLLTROPIN ALFA) INJECTION, SOLUTION [EMD SERONO, INC.]5
METACRESOLINACTIVE INGREDIENTGGO4Y809LOGONAL-F RFF REDI-JECT (FOLLITROPIN) INJECTION, SOLUTION [EMD SERONO, INC.]3
metacresolINACTIVE INGREDIENTGGO4Y809LOINTRON A (INTERFERON ALFA-2B) KIT INTRON A (INTERFERON ALFA-2B) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]3
metacresolINACTIVE INGREDIENTGGO4Y809LOSYMLINPEN (PRAMLINTIDE ACETATE) INJECTION [ASTRAZENECA PHARMACEUTICALS LP]3
metacresolINACTIVE INGREDIENTGGO4Y809LOBYETTA (EXENATIDE) INJECTION [ASTRAZENECA PHARMACEUTICALS LP]2
metacresolINACTIVE INGREDIENTGGO4Y809LOCERENIA (MAROPITANT CITRATE) INJECTION [ZOETIS INC.]2
METACRESOLINACTIVE INGREDIENTGGO4Y809LONATPARA (PARATHYROID HORMONE) (PARATHYROID HORMONE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NPS PHARMACEUTICALS, INC.]2
MetacresolINACTIVE INGREDIENTGGO4Y809LOHUMULIN 70/30 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION [REMEDYREPACK INC. ]1
MetacresolINACTIVE INGREDIENTGGO4Y809LOHUMULIN 70/30 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION [REMEDYREPACK INC. ]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LOLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LOLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LONOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS LLC]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LONOVOLIN70/30 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [REMEDYREPACK INC. ]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LONOVOLIN70/30 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [REMEDYREPACK INC. ]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LOREGRANEX (BECAPLERMIN) GEL [HEALTHPOINT, LTD]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LOREGRANEX (BECAPLERMIN) GEL [SMITH & NEPHEW, INC.]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LOTRESIBA (INSULIN DEGLUDEC INJECTION) INJECTION, SOLUTION [NOVO NORDISK]1
METACRESOLINACTIVE INGREDIENTGGO4Y809LOZOMACTON (SOMATROPIN) KIT [FERRING PHARMACEUTICALS INC.]1